Olr440 inhibitors are a specific class of chemical compounds that target the Olr440 receptor, a protein found primarily within the olfactory system. This receptor is part of the olfactory receptor family, a large group of G-protein-coupled receptors (GPCRs) responsible for detecting odorants and initiating signal transduction pathways that lead to the perception of smell. The Olr440 receptor, like others in this family, plays a critical role in the recognition and discrimination of various odorant molecules. Olr440 inhibitors function by binding to the receptor in a manner that either prevents the receptor from interacting with its natural odorant ligands or alters the receptor's conformation, thereby impeding its ability to transduce the olfactory signal. This interference in the receptor's activity can provide valuable insights into the structural and functional dynamics of olfactory receptors, which are notoriously difficult to study due to their membrane-bound nature and the diversity of ligands they can bind.
The structural design of Olr440 inhibitors typically involves molecular features that allow them to fit precisely within the binding pocket of the Olr440 receptor. These inhibitors may exhibit high specificity for the Olr440 receptor over other olfactory receptors, achieved through detailed understanding and modeling of the receptor's binding site. The development and analysis of Olr440 inhibitors can shed light on the molecular mechanisms underlying olfaction and the broader functions of GPCRs. By studying these inhibitors, researchers can elucidate the structural determinants required for receptor activation or inhibition, explore the receptor's conformational changes upon ligand binding, and investigate the downstream signaling pathways triggered by Olr440 engagement. Additionally, the study of Olr440 inhibitors can contribute to the broader field of chemical biology by offering tools for probing GPCR functions and facilitating the discovery of new receptor-ligand interactions within the olfactory system.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
BCR-ABL tyrosine kinase inhibitor, potentially disrupting signaling pathways regulating Olr440. | ||||||
Erlotinib Hydrochloride | 183319-69-9 | sc-202154 sc-202154A | 10 mg 25 mg | $74.00 $119.00 | 33 | |
EGFR tyrosine kinase inhibitor, could alter cell growth and differentiation pathways influencing Olr440. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Multi-kinase inhibitor, might affect angiogenesis and cell proliferation pathways relevant to Olr440. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $412.00 | 32 | |
Dual EGFR and HER2 inhibitor, potentially modulating signaling pathways relevant to Olr440's function. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $150.00 $920.00 | 5 | |
Multi-targeted receptor tyrosine kinase inhibitor, could disrupt several signaling pathways involving Olr440. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Src family kinase inhibitor, might alter cell proliferation and survival pathways affecting Olr440. | ||||||
Pazopanib | 444731-52-6 | sc-396318 sc-396318A | 25 mg 50 mg | $127.00 $178.00 | 2 | |
Inhibits multiple tyrosine kinases, potentially affecting pathways influencing Olr440, like angiogenesis or cell proliferation. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $205.00 $405.00 | 9 | |
BCR-ABL kinase inhibitor, potentially influencing cell proliferation and survival pathways impacting Olr440. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
CDK4/6 inhibitor, might modulate cell cycle regulation pathways impacting Olr440. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $116.00 $330.00 $510.00 $816.00 $1632.00 | 10 | |
BCL-2 inhibitor, could influence apoptotic pathways potentially relevant to Olr440. | ||||||